Cargando…
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
PURPOSE: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. RESULTS: The NM...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951132/ https://www.ncbi.nlm.nih.gov/pubmed/29780262 http://dx.doi.org/10.2147/CLEP.S151246 |
_version_ | 1783322983435075584 |
---|---|
author | Robsahm, Trude Eid Helsing, Per Nilssen, Yngvar Vos, Linda Rizvi, Syed Mohammad H Akslen, Lars A Veierød, Marit B |
author_facet | Robsahm, Trude Eid Helsing, Per Nilssen, Yngvar Vos, Linda Rizvi, Syed Mohammad H Akslen, Lars A Veierød, Marit B |
author_sort | Robsahm, Trude Eid |
collection | PubMed |
description | PURPOSE: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. RESULTS: The NMMR and the Norwegian Cause of Death Registry provided data on the clinical and histopathological factors as well as the date and cause of death, through June 2015 for all first invasive CMs diagnosed in 2008–2012 (n=8087). Cox regression was used to estimate associations between clinical and pathological factors and CM-specific death. Multiple imputation was used to handle missing data. RESULTS: The CMs were equally distributed between men (49.9%) and women (50.1%), and the median follow-up was 4.0 years (range: 0.08–7.5 years). Trunk was the most common anatomic site (48%), superficial spreading melanoma was the dominant melanoma subtype (68.2%), median Breslow thickness was 1.0 mm, ulceration was present in 23% of CMs, and 91.8% of cases were in a local clinical stage at diagnosis. Compared to women, men were diagnosed at a higher age, with thicker and more-often-ulcerated tumor, and more often were in advanced clinical stages. During follow-up, 1015 patients died due to CM, representing 52.8% of all deaths. The nodular subtype made up the dominant proportion of fatal CM cases (55.3% in women, 64.6% in men). Sex, age, anatomic site (trunk), T-stage, ulceration, clinical stage, and having a second primary CM were associated with increased risk of CM-specific death. CONCLUSION: Our data suggest that the high rate of mortality due to CM observed in Norway is attributable to the more advanced stage of the disease at diagnosis. Most high-risk cases occurred in male patients ≥70 years of age. Efforts to improve awareness and secondary prevention of CM, including warning signs of all melanoma subtypes, are required urgently and should be targeted toward men in particular. |
format | Online Article Text |
id | pubmed-5951132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59511322018-05-18 High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry Robsahm, Trude Eid Helsing, Per Nilssen, Yngvar Vos, Linda Rizvi, Syed Mohammad H Akslen, Lars A Veierød, Marit B Clin Epidemiol Original Research PURPOSE: The purpose of this study was to examine why Norway has the highest rate of mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma Registry (NMMR) enables the study of clinical and histopathological characteristics of patients who die due to CM. RESULTS: The NMMR and the Norwegian Cause of Death Registry provided data on the clinical and histopathological factors as well as the date and cause of death, through June 2015 for all first invasive CMs diagnosed in 2008–2012 (n=8087). Cox regression was used to estimate associations between clinical and pathological factors and CM-specific death. Multiple imputation was used to handle missing data. RESULTS: The CMs were equally distributed between men (49.9%) and women (50.1%), and the median follow-up was 4.0 years (range: 0.08–7.5 years). Trunk was the most common anatomic site (48%), superficial spreading melanoma was the dominant melanoma subtype (68.2%), median Breslow thickness was 1.0 mm, ulceration was present in 23% of CMs, and 91.8% of cases were in a local clinical stage at diagnosis. Compared to women, men were diagnosed at a higher age, with thicker and more-often-ulcerated tumor, and more often were in advanced clinical stages. During follow-up, 1015 patients died due to CM, representing 52.8% of all deaths. The nodular subtype made up the dominant proportion of fatal CM cases (55.3% in women, 64.6% in men). Sex, age, anatomic site (trunk), T-stage, ulceration, clinical stage, and having a second primary CM were associated with increased risk of CM-specific death. CONCLUSION: Our data suggest that the high rate of mortality due to CM observed in Norway is attributable to the more advanced stage of the disease at diagnosis. Most high-risk cases occurred in male patients ≥70 years of age. Efforts to improve awareness and secondary prevention of CM, including warning signs of all melanoma subtypes, are required urgently and should be targeted toward men in particular. Dove Medical Press 2018-05-09 /pmc/articles/PMC5951132/ /pubmed/29780262 http://dx.doi.org/10.2147/CLEP.S151246 Text en © 2018 Robsahm et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Robsahm, Trude Eid Helsing, Per Nilssen, Yngvar Vos, Linda Rizvi, Syed Mohammad H Akslen, Lars A Veierød, Marit B High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry |
title | High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry |
title_full | High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry |
title_fullStr | High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry |
title_full_unstemmed | High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry |
title_short | High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry |
title_sort | high mortality due to cutaneous melanoma in norway: a study of prognostic factors in a nationwide cancer registry |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951132/ https://www.ncbi.nlm.nih.gov/pubmed/29780262 http://dx.doi.org/10.2147/CLEP.S151246 |
work_keys_str_mv | AT robsahmtrudeeid highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry AT helsingper highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry AT nilssenyngvar highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry AT voslinda highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry AT rizvisyedmohammadh highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry AT akslenlarsa highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry AT veierødmaritb highmortalityduetocutaneousmelanomainnorwayastudyofprognosticfactorsinanationwidecancerregistry |